[阿博托毒素A注射用于儿童慢性的纠正:俄罗斯回顾性多中心研究]
O A Klochkova1, A L Kurenkov2,3, G V Argunova4
1Research Institute of Pediatrics and Children's Health in Petrovsky National Research Centre of Surgery, Moscow, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|February 11, 2025
概括
阿博胺毒素A注射有效地减少了神经疾病儿童的慢性唾液流. 这种治疗是安全的,耐受性很好,在唾液控制方面有显著的改善.
科学领域:
- 儿科神经学 儿科神经学
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 慢性是患有神经疾病和神经发育障碍的儿童的常见挑战.
- 有效的治理sialorrhea对于改善生活质量和预防并发症至关重要.
研究的目的:
- 为了评估AbototulinumtoxinA注射在儿科患者的慢性阴毛病的疗效和安全性.
- 分析俄罗斯在多中心环境中使用阿博胺毒素A的经验.
主要方法:
- 对226名儿科患者 (年龄为2.0-17.8岁) 在12个俄罗斯中心接受治疗的回顾性分析.
- 毒素A被注射到唾液腺,一些患者同时接受性治疗.
- 给药剂量包括鼻腺和下部腺注射,提供详细的剂量范围.
主要成果:
- 在79.6%的患者中,abobotulinumtoxinA是唾液的初始治疗方法.
- 在第一次注射后,在93.8%的病例中观察到 significant 的唾液减少.
- 治疗效果平均持续4.9个月,不良事件发生在13.3%的病例中.
结论:
- 阿博胺毒素A注射在治疗慢性儿科尿症方面表现出有效性和安全性.
- 治疗是有益的,即使与性管理相结合.
- 建议进行进一步的研究以优化剂量和治疗方案.
相关概念视频
Anticholinesterase Agents: Poisoning and Treatment
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Effects of EDTA on End-Point Detection Methods
Different methods, such as visual observance of metal-ion indicators, spectroscopic techniques, and potentiometric methods, can determine the endpoint of an EDTA titration.
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
In the visual method, metal-ion indicators (metallochromic dyes), which have distinct colors in their free and complex forms, are added to the mixture to signal the titration's end point. They form stable complexes with metal ions, but these complexes are weaker than the corresponding metal–EDTA complexes. As a result, EDTA...
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Calculating drug dosage and accumulation in multiple-dose regimens is crucial for achieving therapeutic efficacy while avoiding toxicity. This involves determining the plasma drug concentrations over time to optimize dosing schedules. The principle of superposition is fundamental in this process, allowing for the prediction of drug concentration in plasma following multiple doses based on single-dose data.The principle of superposition asserts that the plasma concentration-time curves from...
Drug Dosing: Infants and Children
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...


